Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE 8:- STOCKHOLDERS’ EQUITY (DEFICIENCY) a. Composition of common stock capital: Authorized Issued and outstanding Number of shares December 31, December 31, 2015 2014 2015 2014 Stock of $0.001 par value: Common stock 200,000,000 200,000,000 26,069,154 24,685,604 b. Common stock rights: The Company’s Amended and Restated Certificate of Incorporation authorizes the Company to issue 200,000,000 shares of common stock, par value $0.001 per share. The common stock confers upon its holders the right to participate in the general meetings of the Company, to vote at such meetings (each share represents one vote), to elect board members and to participate in any distribution of dividends or any other distribution of the Company’s property, including the distribution of surplus assets upon liquidation. c. Stock option plans: On December 30, 2005, the Company’s board of directors adopted the Varonis Systems, Inc. 2005 Stock Plan (the “2005 Stock Plan”). As of December 31, 2013, the Company had reserved 4,713,319 shares of common stock available for issuance to employees, directors, officers and consultants of the Company and its subsidiaries. The options generally vest over four years. No awards were granted under the 2005 Stock Plan subsequent to December 31, 2013, and no further awards will be granted under the 2005 Stock Plan. On November 14, 2013, the Company’s board of directors adopted the Varonis Systems, Inc. 2013 Omnibus Equity Incentive Plan (the “2013 Plan”) which was subsequently approved by the Company’s stockholders. The Company initially reserved 1,904,633 shares of common stock for issuance under the 2013 Plan to employees, directors, officers and consultants of the Company and its subsidiaries. The number of shares of common stock available for issuance under the 2013 Plan will be increased on January 1, 2016 and on each January 1 thereafter by four percent (4%) of the number of shares of common stock issued and outstanding on each December 31 immediately prior to the date of increase (rounded down to the nearest whole share), but the amount of each increase will be limited to the number of shares of common stock necessary to bring the total number of shares of Common Stock available for grant and issuance under the 2013 Plan to five percent (5%) of the number of shares of common stock issued and outstanding on each December 31. On January 1, 2016, the share reserve under the 2013 Plan was automatically increased by 1,042,766 shares. Awards granted under the 2013 Plan generally vest over four years. Any award that is forfeited or canceled before expiration becomes available for future grants under the 2013 Plan. A summary of employees’ stock options activities during the year ended December 31, 2015 is as follows: Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 4,080,611 $ 9.697 $ 95,855 6.092 Granted 191,200 $ 28.253 Exercised (1,334,351 ) $ 1.521 Forfeited (154,900 ) $ 25.265 Options outstanding at the end of the period 2,782,560 $ 14.026 $ 21,337 6.246 Vested and expected to vest 2,677,503 $ 13.623 $ 21,284 6.156 Options exercisable at the end of the period 1,794,249 $ 8.841 $ 20,496 5.035 A summary of employees’ stock options activities during the years ended December 31, 2014 and 2013 is as follows: Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 3,233,235 $ 4.033 $ 65,723 5.700 Granted 1,111,940 $ 25.077 Exercised (213,174 ) $ 1.663 Forfeited (51,390 ) $ 19.449 Options outstanding at the end of the period 4,080,611 $ 9.697 $ 95,855 6.092 Vested and expected to vest 3,965,741 $ 9.318 $ 94,581 6.000 Options exercisable at the end of the period 2,620,454 $ 2.638 $ 79,117 4.359 Year ended Number Weighted Aggregate Weighted Options outstanding at the beginning of the year 2,809,923 $ 1.782 $ 43,801 5.952 Granted 541,150 $ 15.267 Exercised (105,021 ) $ 1.239 Forfeited (12,817 ) $ 13.998 Options outstanding at the end of the period 3,233,235 $ 4.033 $ 65,723 5.700 Vested and expected to vest 3,203,465 $ 3.941 $ 65,412 5.668 Options exercisable at the end of the period 2,550,694 $ 1.473 $ 58,377 4.799 The weighted average grant date fair values of options granted during the years ended December 31, 2015, 2014 and 2013 were $28.637, $14.087 and $14.002, respectively. The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders exercised their options on the last date of the exercise period. Total intrinsic value of options exercised for the years ended December 31, 2015, 2014 and 2013 were $27,885, $4,800 and $2,218, respectively. As of December 31, 2015 and 2014, there were $11,779 and $17,016, respectively, of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2005 Stock Plan and 2013 Plan. This cost is expected to be recognized over a period of approximately 2.416 and 3.173 years, respectively. The options outstanding as of December 31, 2015 have been separated into ranges of exercise price as follows: Range of Options Weighted Weighted Options Weighted Weighted $0.901 - 1.576 978,178 2.923 $ 1.224 978,178 2.923 $ 1.224 $6.230 - 8.800 145,693 5.920 $ 6.786 137,391 5.895 $ 6.785 $12.470 378,149 7.177 $ 12.470 261,065 7.159 $ 12.470 $19.510 - 21.660 640,743 8.609 $ 21.219 211,571 8.477 $ 21.237 $22.010 - 24.230 309,222 8.298 $ 22.293 127,326 8.280 $ 22.365 $29.880 154,200 9.148 $ 29.880 — 0.000 $ 0.000 $39.86 176,375 8.227 $ 39.860 78,718 8.227 $ 39.860 2,782,560 6.246 $ 14.026 1,794,249 5.035 $ 8.841 The options outstanding as of December 31, 2014 have been separated into ranges of exercise price as follows: Range of exercise price Options outstanding as of December 31, 2014 Weighted average remaining contractual life (years) Weighted average exercise price Options exercisable as of December 31, 2014 Weighted average remaining contractual life (years) Weighted average exercise price of options exercisable $0.070 - 0.901 594,591 2.504 $ 0.728 594,591 2.504 $ 0.728 $1.039 - 1.576 1,651,595 4.255 $ 1.261 1,651,595 4.255 $ 1.261 $6.230 - 8.800 174,222 6.886 $ 6.724 135,318 6.815 $ 6.739 $12.470 413,680 8.175 $ 12.470 184,504 8.152 $ 12.470 $21.00 - 24.23 1,039,073 9.476 $ 21.611 54,446 8.812 $ 21.764 $39.86 207,450 9.227 $ 39.860 — 0.000 $ 0.000 4,080,611 6.092 $ 9.697 2,620,454 4.359 $ 2.638 d. Options issued to consultants: The Company’s outstanding options granted to consultants for pre-sales and marketing services as of December 31, 2015 were as follows: Issuance date Options for shares of common stock Exercise price per share Options exercisable Exercisable through (number) (number) February 2013 3,000 $ 12.470 2,125 February 2023 August 2013 5,000 $ 21.140 2,917 August 2023 October 2013 823 $ 24.230 479 October 2023 March 2014 14,438 $ 39.860 6,422 March 2024 May 2014 8,700 $ 22.010 3,444 May 2024 August 2014 219 $ 21.000 354 August 2024 November 2014 12,000 $ 21.660 3,250 November 2024 May 2015 5,250 $ 19.510 — May 2025 49,430 18,991 The Company’s outstanding options granted to consultants for sales and pre-marketing services as of December 31, 2014 were as follows: Issuance date Options for Exercise price Options Exercisable (number) (number) December 2006 15,000 $ 0.901 15,000 December 2016 February 2013 4,000 $ 12.470 1,832 February 2023 August 2013 5,000 $ 21.140 1,665 August 2023 October 2013 1,250 $ 24.230 363 October 2023 March 2014 16,450 $ 39.860 - March 2024 May 2014 8,700 $ 22.010 - May 2024 August 2014 36,250 $ 21.000 - August 2024 November 2014 12,000 $ 21.660 - November 2024 98,650 18,860 e. Restricted stock units: The following provides a summary of the restricted stock unit activity for the Company for the year ended December 31, 2015: Number of Weighted- Outstanding as of January 1, 2015 27,470 $ 21.00 Granted 685,065 $ 23.30 Vested (36,789 ) $ 19.90 Forfeited (32,240 ) $ 23.56 Unvested as of December 31, 2015 643,506 $ 23.38 The following provides a summary of the restricted stock unit activity for the Company for the year ended December 31, 2014: Number of Weighted- Outstanding as of January 1, 2014 - $ - Granted 31,905 $ 21.00 Vested (4,435 ) $ 21.00 Forfeited - $ - Unvested as of December 31, 2014 27,470 $ 21.00 f. 2015 Employee Stock Purchase Plan On May 5, 2015, the Company’s stockholders approved the Varonis Systems, Inc. 2015 Employee Stock Purchase Plan (the “ESPP”), which the Company’s board of directors had adopted on March 19, 2015. The ESPP became effective as of June 30, 2015. The ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount through payroll deductions of up to 15% of their eligible compensation, at not less than 85% of the fair market value of the Company’s common stock on the first day or last trading day in the offering period, subject to any plan limitations. The Company initially reserved 500,000 shares of common stock for issuance under the ESPP. The number of shares available for issuance under the ESPP will be increased on January 1, 2016, and will increase each January thereafter, by an amount equal to the lesser of (i) one percent (1%) of the number of shares of common stock issued and outstanding on each December 31 immediately prior to the date of increase, except that the amount of each such increase will be limited to the number of shares of common stock necessary to bring the total number of shares of common stock available for issuance under the ESPP to two percent (2%) of the number of shares of common stock issued and outstanding on each such December 31, or (ii) 400,000 shares of common stock. On January 1, 2016, the share reserve under the ESPP was automatically increased by 21,383 shares. The ESPP will continue in effect until the earlier of (i) the date when no shares of common stock are available for issuance thereunder or (ii) June 30, 2025; unless terminated prior thereto by the Company’s board of directors or compensation committee, each of which has the right to terminate the ESPP at any time. g. Stock-based compensation expense for employees and consultants: The Company recognized non-cash stock-based compensation expense in the consolidated statements of operations as follows (in thousands): Year ended 2015 2014 2013 Cost of revenues $ 419 $ 192 $ 39 Research and development 1,954 1,198 551 Sales and marketing 3,041 2,478 841 General and administrative 2,380 796 357 Total $ 7,794 $ 4,664 $ 1,788 |